10-KPeriod: FY2012

EIDP, Inc. Annual Report, Year Ended Dec 31, 2012

Filed February 7, 2013For Securities:CTA-PBCTA-PA

Summary

E.I. du Pont de Nemours and Company (DuPont) filed its 2012 10-K on February 7, 2013, reporting on its performance for the fiscal year ending December 30, 2012. The company, a global science and engineering leader founded in 1802, operates across diverse segments including Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Chemicals, Performance Materials, and Safety & Protection. A significant event during the year was the definitive agreement to sell its Performance Coatings business for approximately $4.9 billion, with the transaction closing on February 1, 2013. This divestiture resulted in the segment's results being presented as discontinued operations. DuPont's strategy centers on leveraging science to address global challenges such as food security, reduced fossil fuel dependence, and safety and environmental protection. The company reported total net sales of $34.8 billion for 2012, a 3% increase driven by strong performance in Agriculture, Nutrition & Health, and Industrial Biosciences, partially offset by declines in other segments, notably Performance Chemicals. International sales represented approximately 60% of total net sales, with developing markets showing significant growth. The company emphasizes innovation through substantial research and development investment, with Agriculture being a major focus for R&D spending.

Financial Statements
Beta
Revenue$34.81B
Cost of Revenue$21.40B
Gross Profit$13.41B
R&D Expenses$2.12B
SG&A Expenses$5.89B
Operating Expenses$32.22B
Operating Income$5.37B
Interest Expense$464.00M
Net Income$2.78B
EPS (Basic)$2.94
EPS (Diluted)$2.91
Shares Outstanding (Basic)933.27M
Shares Outstanding (Diluted)942.20M

Key Highlights

  • 1Total net sales for 2012 were $34.8 billion, an increase of 3% compared to 2011, driven by growth in Agriculture, Nutrition & Health, and Industrial Biosciences segments.
  • 2The company entered into an agreement to sell its Performance Coatings business for approximately $4.9 billion, which was completed in early February 2013, with its results presented as discontinued operations.
  • 3Agriculture, including DuPont Pioneer (seeds) and DuPont Crop Protection, accounted for approximately 50% of the company's total research and development expense in 2012.
  • 4Pioneer brand seed sales represented 21% of consolidated net sales in 2012, highlighting the significance of the agriculture segment.
  • 5Global sales reached $34.8 billion, with approximately 60% generated from customers outside the U.S. and a 6% increase in sales within developing markets.
  • 6The company continued to invest heavily in R&D, with $2.07 billion spent in 2012, reflecting its commitment to innovation across its diverse business segments.
  • 7DuPont maintained a strong commitment to shareholder returns, paying continuous quarterly dividends since 1904 and engaging in share repurchase programs.

Frequently Asked Questions

In 2012, DuPont's net sales increased by 3% to $34.8 billion. The primary revenue drivers were the Agriculture segment (including DuPont Pioneer and DuPont Crop Protection), Nutrition & Health, and Industrial Biosciences. Growth in these segments was partially offset by lower sales in other segments, particularly Performance Chemicals.

A major event was the definitive agreement in the third quarter of 2012 to sell the Performance Coatings business for approximately $4.9 billion. This sale was completed on February 1, 2013. In 2011, DuPont had acquired Danisco for $6.4 billion, which significantly impacted the Nutrition & Health and Industrial Biosciences segments in 2012.

DuPont has a significant global presence, with approximately 60% of its consolidated net sales generated from customers outside the United States. The company experienced robust growth in developing markets, which saw a 6% increase in sales and represented 34% of total company sales in 2012. This indicates a strategic focus on expanding its presence in these high-growth regions.

DuPont identified several key risks, including potential price increases for energy and raw materials, the need to continuously develop and market new products while managing product life cycles, potential impacts from litigation and environmental matters, and risks associated with process safety and product stewardship. The company also highlighted risks related to market acceptance of biotechnology products and changes in government policies and global economic conditions.